Insider Transactions in Q1 2023 at Agilon Health, Inc. (AGL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
97,290
-26.01%
|
$2,724,120
$28.7 P/Share
|
|
Mar 24
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
97,290
+20.64%
|
$291,870
$3.0 P/Share
|
|
Mar 23
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
22,710
-7.58%
|
$635,880
$28.71 P/Share
|
|
Mar 23
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,710
+7.05%
|
$68,130
$3.0 P/Share
|
|
Mar 23
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-12.74%
|
$226,632
$28.04 P/Share
|
|
Mar 23
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+11.3%
|
$64,752
$8.99 P/Share
|
|
Mar 22
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-12.74%
|
$218,538
$27.84 P/Share
|
|
Mar 22
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+11.3%
|
$64,752
$8.99 P/Share
|
|
Mar 16
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-10.78%
|
$625,000
$25.36 P/Share
|
|
Mar 16
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+22.6%
|
$25,000
$1.0 P/Share
|
|
Mar 16
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
60,000
-17.82%
|
$1,560,000
$26.09 P/Share
|
|
Mar 16
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+15.12%
|
$180,000
$3.0 P/Share
|
|
Mar 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
55,000
-49.81%
|
$1,265,000
$23.81 P/Share
|
|
Mar 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+47.52%
|
$400,000
$4.49 P/Share
|
|
Mar 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
60,000
-29.11%
|
$1,380,000
$23.8 P/Share
|
|
Mar 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+29.72%
|
$95,000
$1.0 P/Share
|
|
Mar 15
2023
|
John William Wulf Director |
SELL
Open market or private sale
|
Direct |
80,000
-39.33%
|
$1,840,000
$23.82 P/Share
|
|
Mar 15
2023
|
John William Wulf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+28.23%
|
$320,000
$4.5 P/Share
|
|
Mar 08
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$194,256
$24.44 P/Share
|
|
Mar 08
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$64,752
$8.99 P/Share
|
|
Mar 07
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$194,256
$24.36 P/Share
|
|
Mar 07
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$64,752
$8.99 P/Share
|
|
Feb 17
2023
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,078
+50.0%
|
-
|
|
Feb 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$178,068
$22.98 P/Share
|
|
Feb 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$64,752
$8.99 P/Share
|
|
Feb 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
28,555
-52.7%
|
$656,765
$23.37 P/Share
|
|
Feb 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,555
+34.51%
|
$28,555
$1.0 P/Share
|
|
Feb 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
25,881
-71.28%
|
$569,382
$22.99 P/Share
|
|
Feb 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,881
+41.62%
|
$207,048
$8.99 P/Share
|
|
Feb 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
50,000
-66.12%
|
$1,100,000
$22.98 P/Share
|
|
Feb 14
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+27.88%
|
$100,000
$2.0 P/Share
|
|
Feb 02
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
30,782
-74.7%
|
$677,204
$22.99 P/Share
|
|
Feb 02
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,782
+42.76%
|
$246,256
$8.99 P/Share
|
|
Feb 01
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$113,316
$21.76 P/Share
|
|
Feb 01
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$43,168
$8.99 P/Share
|
|
Jan 20
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$102,524
$19.92 P/Share
|
|
Jan 20
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$43,168
$8.99 P/Share
|
|
Jan 19
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
10,792
-50.86%
|
$205,048
$19.73 P/Share
|
|
Jan 19
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,792
+33.71%
|
$86,336
$8.99 P/Share
|
|
Jan 18
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
20,723
-44.71%
|
$393,737
$19.78 P/Share
|
|
Jan 18
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,723
+30.9%
|
$62,169
$3.0 P/Share
|
|
Jan 17
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,722
-50.09%
|
$488,718
$19.91 P/Share
|
|
Jan 17
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,722
+33.38%
|
$77,166
$3.0 P/Share
|
|
Jan 06
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
2,698
-20.56%
|
$40,470
$15.46 P/Share
|
|
Jan 06
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,698
+17.05%
|
$21,584
$8.99 P/Share
|
|
Jan 05
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
2,698
-20.56%
|
$40,470
$15.51 P/Share
|
|
Jan 05
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,698
+17.05%
|
$21,584
$8.99 P/Share
|